Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension

Angiotensin Ii Receptor ◽

Effects of Olmesartan, an Angiotensin II Receptor Blocker, and Amlodipine, a Calcium Channel Blocker, on Cardio-Ankle Vascular Index (CAVI) in Type 2 Diabetic Patients with Hypertension

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.erratum2009_912 ◽

2009 ◽

Vol 16 (6) ◽

pp. 912-912

Author(s):

Yoh Miyashita ◽

Atsuhito Saiki ◽

Kei Endo ◽

Noriko Ban ◽

Takashi Yamaguchi ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Angiotensin Ii Receptor ◽

Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

Hypertension Research ◽

10.1038/hr.2012.45 ◽

2012 ◽

Vol 35 (8) ◽

pp. 874-881 ◽

Cited By ~ 12

Author(s):

Masanori Abe ◽

Noriaki Maruyama ◽

Hiroko Suzuki ◽

Yuki Fujii ◽

Midori Ito ◽

...

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Angiotensin Receptor Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Diabetic Patients ◽

Angiotensin Receptor ◽

Elevated circulating alpha-klotho by angiotensin II receptor blocker losartan is associated with reduction of albuminuria in type 2 diabetic patients

Journal of the Renin-Angiotensin-Aldosterone System ◽

10.1177/1470320313475905 ◽

2013 ◽

Vol 15 (4) ◽

pp. 487-490 ◽

Cited By ~ 16

Author(s):

Su Chi Lim ◽

Jian-Jun Liu ◽

Tavintharan Subramaniam ◽

Chee Fang Sum

Keyword(s):

Angiotensin Ii ◽

Receptor Blocker ◽

Diabetic Patients ◽

Angiotensin Ii Receptor ◽

Protective Effects of Efonidipine, a T- and L-Type Calcium Channel Blocker, on Renal Function and Arterial Stiffness in Type 2 Diabetic Patients with Hypertension and Nephropathy

Journal of Atherosclerosis and Thrombosis ◽

10.5551/jat.1628 ◽

2009 ◽

Vol 16 (5) ◽

pp. 568-575 ◽

Cited By ~ 47

Author(s):

Hidehisa Sasaki ◽

Atsuhito Saiki ◽

Kei Endo ◽

Noriko Ban ◽

Takashi Yamaguchi ◽

...

Keyword(s):

Renal Function ◽

Arterial Stiffness ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Diabetic Patients ◽

Protective Effects ◽

Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentation Index in Hypertensive Patients

The American Journal of the Medical Sciences ◽

10.1097/maj.0b013e3181d658c4 ◽

2010 ◽

Vol 339 (5) ◽

pp. 433-439 ◽

Cited By ~ 16

Author(s):

Masayuki Doi ◽

Toru Miyoshi ◽

Satoshi Hirohata ◽

Shigeshi Kamikawa ◽

Hiroko Ogawa ◽

...

Keyword(s):

Angiotensin Ii ◽

Combination Therapy ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Augmentation Index ◽

Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients

Protective Effects of an Angiotensin II Receptor Blocker and a Long-Acting Calcium Channel Blocker against Cardiovascular Organ Injuries in Hypertensive Patients

Hypertension Research ◽

10.1291/hypres.28.351 ◽

2005 ◽

Vol 28 (4) ◽

pp. 351-359 ◽

Cited By ~ 20

Author(s):

Toshihiko ISHIMITSU ◽

Tsutomu KOBAYASHI ◽

Takeaki HONDA ◽

Masaki TAKAHASHI ◽

Junichi MINAMI ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Receptor Blocker ◽

Protective Effects ◽

Angiotensin Ii Receptor ◽

Hypertensive Patients ◽

Long Acting

Letter regarding the article, “A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients”

Drug Design Development and Therapy ◽

10.2147/dddt.s185297 ◽

2019 ◽

Vol Volume 13 ◽

pp. 385-386

Author(s):

Ling-Yue Zhao ◽

Yi-Jun Luo ◽

Jing Zhu

Keyword(s):

Clinical Trial ◽

Angiotensin Ii ◽

Diabetic Patients ◽

Angiotensin Ii Receptor ◽

Double Blind ◽

Double Blind Clinical Trial ◽

Receptor Blockers ◽

Erratum to: Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker

Clinical and Experimental Nephrology ◽

10.1007/s10157-009-0185-3 ◽

2009 ◽

Vol 13 (4) ◽

pp. 307-307

Author(s):

Takashi Uzu ◽

Masayoshi Sakaguchi ◽

Yukiyo Yokomaku ◽

Shinji Kume ◽

Masami Kanasaki ◽

...

Keyword(s):

Blood Pressure ◽

Sodium Intake ◽

Diabetic Patients ◽

Angiotensin Ii Receptor ◽

High Sodium ◽

High Sodium Intake ◽

Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT1 Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice

PLoS ONE ◽

10.1371/journal.pone.0082082 ◽

2013 ◽

Vol 8 (12) ◽

pp. e82082 ◽

Cited By ~ 4

Author(s):

Kazi Rafiq ◽

Shamshad J. Sherajee ◽

Hirofumi Hitomi ◽

Daisuke Nakano ◽

Hiroyuki Kobori ◽

...

Keyword(s):

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Renal Injury ◽

Channel Blocker ◽

Diabetic Mice ◽

At1 Receptor Blocker ◽

Beneficial Effects ◽

Combined Effect of Angiotensin II Receptor Blocker and Either a Calcium Channel Blocker or Diuretic on Day-by-Day Variability of Home Blood Pressure

Hypertension ◽

10.1161/hypertensionaha.111.189217 ◽

2012 ◽

Vol 59 (6) ◽

pp. 1132-1138 ◽

Cited By ~ 72

Author(s):

Yoshio Matsui ◽

Michael F. O'Rourke ◽

Satoshi Hoshide ◽

Joji Ishikawa ◽

Kazuyuki Shimada ◽

...

Keyword(s):

Blood Pressure ◽

Angiotensin Ii ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Home Blood Pressure ◽

Combined Effect ◽

Angiotensin Ii Receptor ◽

Day By Day